Six beautiful images — choose your favorites
Emory’s Office of Postdoctoral Education is holding a Best Image contest. The deadline to vote is this Thursday, April 30. You can look at these beautiful images (and guess exactly what they are, based on what lab they come from), but to VOTE, you need to go to the OPE site. This is part of […]
Congratulations to AAAS Mass Media fellows
Anzar Abbas –> HHMI, Katie Strong –> SacBee
Risk triangle: immune gene, insecticide, Parkinson’s
A Emory/UCLA study is the first finding a connection between exposure to pyrethroids, found in common household insecticides, and genetic risk for Parkinson’s. Possible mechanism: MHC expression and neuroinflammation.
Fragile X syndrome: building a case for a treatment strategy
Decision-making time in mice. Further progress along these lines may lead to a clinical trial.
Emory = oxytocin hot spot
In terms of research, of course!
Honokiol, Jack of all trades
The magnolia-derived compound honokiol was discovered by Emory dermatologist Jack Arbiser. UChicago researchers show it has positive effects in a heart disease model.
Leslee Shaw explains coronary artery calcium scoring
And why it’s a relatively cost-effective test for predicting heart disease
Brain surgery with a light touch
In epilepsy surgery, how much effect does ablation of the hippocampus and amygdala have on cognitive function — if the surgeon avoids an open resection?
DBS for drug-resistant epilepsy
This guy (Robert Gross, with green mask) does some amazing things. Some takeaway points to go with the new Emory Medicine feature.
Low doses of imatinib can stimulate innate immunity
Ties in with “Emperor of All Maladies” finale — imatinib, a prominent example of a targeted therapy, may have utility in fighting infection/modulating the immune system